Another theory suggests that rather than humoral immunity, cell-mediated immunity against islet cells plays a major role in autoantibody-negative type 1 diabetes in patients taking PD-1 inhibitor therapy [10]. Here, PDCD1 is linked to type 1 diabetes mellitus.